Friday, December 11, 2009

Medical News

Medical News


Off-licence recombinant activated factor VII guidelines often ignored

Posted: 10 Dec 2009 04:00 PM PST

A study of hospitals in Australia and New Zealand has revealed that although most have guidelines for off-license recombinant activated factor VII use, the majority of patients are not treated in accordance with all elements of the guideline.

Stent-assisted coiling of aneurysms lowers recurrence but at cost of more complications

Posted: 10 Dec 2009 04:00 PM PST

Stent-assisted coiling of intracranial aneurysms is associated with improved angiographic outcomes but also more procedure-related complications compared with stent-free coiling, researchers report.

PSA density effectively predicts Gleason score upgrading after prostate surgery

Posted: 10 Dec 2009 04:00 PM PST

Prostate-specific antigen density significantly predicts Gleason score upgrading in men who are treated with radical prostatectomy for prostate cancer, report researchers.

<i>BRIP1</i> mutations found in hereditary prostate cancer families

Posted: 10 Dec 2009 04:00 PM PST

Researchers have found that men with hereditary prostate cancer have missense, but not protein truncating, variants in the BRIP1 gene.

Tamoxifen following chemotherapy improves breast cancer outcome

Posted: 10 Dec 2009 04:00 PM PST

Addition of chemotherapy to standard tamoxifen treatment for postmenopausal women with node-positive breast cancer significantly improves disease-free survival, and this benefit is maximized when the tamoxifen follows chemotherapy, US researchers report in The Lancet.

PSA density effectively predicts Gleason score upgrading after prostate surgery

Posted: 10 Dec 2009 04:00 PM PST

Prostate-specific antigen density significantly predicts Gleason score upgrading in men who are treated with radical prostatectomy for prostate cancer, report researchers.

<i>BRIP1</i> mutations found in hereditary prostate cancer families

Posted: 10 Dec 2009 04:00 PM PST

Researchers have found that men with hereditary prostate cancer have missense, but not protein truncating, variants in the BRIP1 gene.

Adiponectin may be marker for metabolic syndrome in menopausal women

Posted: 10 Dec 2009 04:00 PM PST

Adiponectin may be a marker for the metabolic syndrome in overweight and obese postmenopausal women with abnormal waist circumferences, say researchers who found low adiponectin levels in this group.

<i>PTPN1</i> variants are associated with high total and LDL cholesterol

Posted: 10 Dec 2009 04:00 PM PST

Three variants in the protein tyrosine phosphatase non-receptor type 1 gene are associated with elevated total and low-density lipoprotein cholesterol in men of normal weight, show study results.

Diabetes impacts myocardial postconditioning success

Posted: 10 Dec 2009 04:00 PM PST

Administration of the volatile anesthetic desflurane on reoxygenation of hypoxic myocardium can provoke a protective postconditioning response even in diabetic patients, a laboratory study indicates.

Anemia linked to subclinical CVD markers in men with Type 2 diabetes

Posted: 10 Dec 2009 04:00 PM PST

Study findings suggest that anemia is associated with an increased cardiovascular risk profile in men with Type 2 diabetes.

Cardiotoxicity of cancer therapies raised again; co-operation of cardiologists and oncologists urged

Posted: 10 Dec 2009 04:00 PM PST

Cardiologists and oncologists should work together to avoid the adverse cardiovascular effects of certain chemotherapies, recommend authors of a review published in the Journal of the National Cancer Institute.

Additional antithrombotics increase bleeding risk in MI patients

Posted: 10 Dec 2009 04:00 PM PST

The risk for bleeding associated with antithrombotic treatment among myocardial infarction patients increases in proportion to the number of antithrombotic drugs used, report researchers in The Lancet.

Tamoxifen following chemotherapy improves breast cancer outcome

Posted: 10 Dec 2009 04:00 PM PST

Addition of chemotherapy to standard tamoxifen treatment for postmenopausal women with node-positive breast cancer significantly improves disease-free survival, and this benefit is maximized when the tamoxifen follows chemotherapy, US researchers report in The Lancet.

No comments:

Post a Comment